United States· US:0069-1307_a2e74269-0093-454f-963e-35c7c2f4f1ba

RETACRIT

A medicinal product containing epoetin, registered in United States by Pfizer Laboratories Div Pfizer Inc.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedRETACRITATC—REGISTER NO.US:0069-1307_a2e74269…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
EPOETIN
Manufacturer
Pfizer Laboratories Div Pfizer Inc
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0069130710
    10 VIAL, SINGLE-DOSE in 1 CARTON (0069-1307-10) / 1 mL in 1 VIAL, SINGLE-DOSE (0069-1307-01)
  • ndc11
    0069-1307-10

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Epoetin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All epoetin products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Erypo
  • Belgium · Eprex
  • Czechia · Eprex
  • Germany · Erypo Fs
  • Spain · Eprex
  • France · Eprex
  • United Kingdom (Northern Ireland) · Eprex
  • Greece · Eprex
  • Iceland · Abseamed, Binocrit
  • Italy · Eprex
  • Liechtenstein · Binocrit, Epoetin Alfa Hexal
  • Luxembourg · Eprex
  • Netherlands · Eprex
  • Norway · Abseamed, Binocrit
  • Portugal · Eprex
  • Slovenia · Eprex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/00bf2cb8-0377-42eb-a09d-e73e23935dd1
GET /v1/drugs/00bf2cb8-0377-42eb-a09d-e73e23935dd1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS; SUBCUTANEOUS",
  "source": "ndc",
  "strength": "4000",
  "substance": "EPOETIN",
  "productndc": "0069-1307",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "[iU]/mL",
  "application_number": "BLA125545",
  "marketing_category": "BLA"
}

See everything about epoetin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.